Panagora Asset Management’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Panagora Asset Management’s Portfolio MRNS Stock Details MRNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-442	Closed	-$5K	–	2953
2020 Q4	$5K	Buy	+442	New	+$6.16K	﹤0.01%	2488
2017 Q3	–	Sell	-893	Closed	-$5K	–	2531
2017 Q2	$5K	Sell	893 -13,100	-94%	-$70.8K	﹤0.01%	2509
2017 Q1	$99K	Hold	13,993	–	–	﹤0.01%	1868
2016 Q4	$57K	Hold	13,993	–	–	﹤0.01%	2073
2016 Q3	$102K	Buy	+13,993	New	+$94.6K	﹤0.01%	1963

Other funds holding MRNS

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Panagora Asset Management's MRNS Position: Q1 2021 in Review

Panagora Asset Management sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q1 2021, closing a stake of 442 shares — an estimated $5K sold.

Panagora Asset Management first reported a position in MRNS in Q3 2016 and held it in 5 quarters. The position peaked at $102K in Q3 2016. 87 funds tracked by Wall St. Rank hold MRNS as of Q1 2021.

Panagora Asset Management reported no remaining Marinus Pharmaceuticals, Inc position as of Q1 2021 after selling out during the quarter.
Panagora Asset Management sold 442 Marinus Pharmaceuticals, Inc shares in Q1 2021, an estimated $5K.
Panagora Asset Management first reported a position in Marinus Pharmaceuticals, Inc in Q3 2016 and held it in 5 quarters.
Panagora Asset Management's Marinus Pharmaceuticals, Inc position peaked at $102K in Q3 2016.
87 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q1 2021.

Based on Panagora Asset Management's 13F filing for Q1 2021, filed 12 May 2021.